Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease: Dawn of a New Era Roger A. Barker, Malin Parmar, Lorenz Studer, Jun Takahashi Cell Stem Cell Volume 21, Issue 5, Pages 569-573 (November 2017) DOI: 10.1016/j.stem.2017.09.014 Copyright © 2017 Elsevier Inc. Terms and Conditions
Figure 1 Overview of Cells for Clinical Trials Possible donor cells explored within GForce-PD include human embryonic stem cells (ES cells) and induced pluripotent stem cells (iPSCs) from non-matched or HLA-matched donors (left side) as well as patient-specific iPSCs (right side). Cell Stem Cell 2017 21, 569-573DOI: (10.1016/j.stem.2017.09.014) Copyright © 2017 Elsevier Inc. Terms and Conditions